Acer Therapeutics Inc Sustainability Reports
Pharmaceutical company focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases, such as OLPRUVA and EDSIVO.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300BRA7GF5PCH1L04
FIGI: BBG001S7Q351
1 reports from 2019 to 2019
